Bosch Launches AIM 8 Series, the New Generation of Fully Automated Inspection Machines
At Interpack 2014, Bosch Packaging Technology, a leading supplier of process and packaging technology, reveals a vial inspection machine of the new AIM 8 series. This machine is the first of the new generation of fully automated inspection machines by the Inspection Technology sector of Bosch Packaging Technology, which was founded in the beginning of 2012 following the acquisition of Eisai Machinery.
In the future, the series will be completed by additional models to cover further parenteral liquid container types, such as syringes, cartridges and ampoules. The AIM 8 series is characterised by a modular design, which allows an easy adaptation of the machines to customer-specific requirements. “With its range of different modules, we can flexibly tailor the AIM 8 to customer specifications, for instance by choosing from standardized inspection units or adding an extra inspection table,” Katsumi Shimizu, technical project leader at Bosch Packaging Technology KK in Japan explains.
Higher Output and Improved Camera System
The basic module of the AIM 8 is equipped with a CMOS camera-based particle inspection system and a table for up to five inspection stations. Each station can in turn be equipped with a wide range of different inspection units. Most of these units combine two inspection types, leading to significant space-savings on the tables. Depending on their requirements, customers can expand this main module by connecting it to a sub-module containing an additional inspection table, as well as to a pre-spin table to reduce bubbles in the liquid or homogenize suspensions.
In contrast to previous series, a camera system is integrated into the main module as standard particle inspection unit. The new AIM 8 series is designed to inspect up to 600 containers per minute for product and cosmetic container defects, such as particles inside liquid pharmaceuticals or scratches and spots on the container. The machine model that Bosch presents at Interpack 2014 handles 450 vials per minute. Depending on product requirements and customer preferences, the proven light transmission-based SD (Static Division) system for the inspection of moving objects and fill levels is available as an option.
“During the development of the AIM 8 series, Bosch put special emphasis on standardizing core mechanical and electrical parts and inspection units to secure faster delivery of machines and service response times,” Katsumi Shimizu explains. “Moreover, the puck transport system ensures quick and easy size changeover and safe container handling.”
ETIM Tablet Inspection: A Novelty Outside of Japan
Bosch Packaging Technology presents another novelty at Interpack 2014. The fully automated inspection machine ETIM for tablets was initially developed exclusively for the Japanese market and now makes its first appearance outside of Japan. “Customer requirements regarding product quality are particularly high in Japan. We believe that our international pharmaceutical customers can greatly profit from these standards and our respective developments,” Kenji Hanawa, vice president of the pharmaceutical Inspection Technology sector of Bosch Packaging Technology, explains.
The ETIM is designed to flexibly handle different types and shapes of tablets at output rates of up to 300 000 per hour. The inspection machine identifies tablet defects such as coloration, breakage, and foreign particles as small as 50 micrometers in size. The highly accurate camera-based imaging system ensures a 360 degree inspection of each tablet. It simultaneously inspects the tablet surface and its peripheral edge with a single camera, presenting the information as five images on the operating screens. The opposite side is inspected with the help of a precise tablet flip-over during transport. This leads to all-around inspection by avoiding blind spots or dead angles. “In addition, Bosch is currently working on a new generation for the global market with even higher precision and output,” Kenji Hanawa concludes.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance